Fibrin sealant, a two-component substance consisting of thrombin and fibrinogen, is used as a hemostatic or adhesive in various surgical solutions. In clinical practice, a fibrin sealant consists of a concentrated solution of fibrinogen and Factor XIII, which combine with a solution of calcium and thrombin to form a coagulum that stimulates clotting. Beriplast P and TISSEEL are some of the commercially available fibrin sealants.
The Americas accounted for 48% of the market share during the forecast period. Growing public awareness, increase in product launches, and numerous FDA approvals for novel instruments are expected to drive the market in this region.

The global Fibrin Sealants market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Fibrin Sealants volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fibrin Sealants market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Fibrin Sealants in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Fibrin Sealants manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Baxter International
CSL Behring
Johnson & Johnson (Ethicon)
Asahi Kasei Medical
C.R. Bard
Hualan Biological
Harvest Technologies
Kaketsuken
LifeBond
Pharming Group
Sea Run
Shanghai RAAS
STB Lifesaving Technologies
Tissuemed
Z-Medica

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
2mL/Set
4mL/Set
10mL/Set

Segment by Application
Hospitals
Clinics
Other